Imaging Hodgkin and non-Hodgkin lymphoma in the head and neck

被引:58
作者
Aiken, Ashley H. [1 ]
Glastonbury, Christine [2 ]
机构
[1] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Radiol, San Francisco, CA 94110 USA
[2] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA
关键词
lymphoma; head and neck; Hodgkin lymphoma; non-Hodgkin lymphoma;
D O I
10.1016/j.rcl.2008.03.001
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Hodgkin (HL) and non-Hodgkin lymphoma (NHL) involving the head and neck have many overlapping imaging features. Definitive diagnosis depends on histology, but imaging trends may help distinguish lymphoma from other common pathologic entities in the head and neck. CT is useful for staging and assessing bony involvement, whereas MR imaging is performed for soft tissue detail in extranodal disease, especially when there is transpatial disease or intracranial or intraspinal extension. Positron emission tomography has become an important part of staging andsurveillance imaging and is particularly useful to distinguish posttreatment fibrosis and residual tumor.
引用
收藏
页码:363 / 378
页数:16
相关论文
共 35 条
[1]  
ABBONDANZO SL, 1995, CANCER, V75, P1281, DOI 10.1002/1097-0142(19950315)75:6<1281::AID-CNCR2820750610>3.0.CO
[2]  
2-I
[3]  
Ansell SM, 1999, SEMIN ONCOL, V26, P316
[4]   Treatment of non-Hodgkin's lymphoma of Waldeyer's ring: Radiotherapy versus chemotherapy versus combined therapy [J].
Aviles, A ;
Delgado, S ;
Ruiz, H ;
delaTorre, A ;
Guzman, R ;
Talavera, A .
ORAL ONCOLOGY, 1996, 32B (01) :19-23
[5]   AIDS-related lymphomas: from pathogenesis to pathology [J].
Carbone, A ;
Gloghini, A .
BRITISH JOURNAL OF HAEMATOLOGY, 2005, 130 (05) :662-670
[6]  
CARBONE PP, 1971, CANCER RES, V31, P1860
[7]   Primary non-Hodgkin's lymphoma of the nose and nasopharynx: Clinical features, tumor immunophenotype, and treatment outcome in 113 patients [J].
Cheung, MMC ;
Chan, JKC ;
Lau, WH ;
Foo, W ;
Chan, PTM ;
Ng, CS ;
Ngan, RKC .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (01) :70-77
[8]   Positron emission tomography with 18F-FDG to detect residual disease after therapy for malignant lymphoma [J].
Cremerius, U ;
Fabry, U ;
Neuerburg, J ;
Zimny, M ;
Osieka, R ;
Buell, U .
NUCLEAR MEDICINE COMMUNICATIONS, 1998, 19 (11) :1055-1063
[9]  
Das Sudip, 2005, Cancer Imaging, V5, P167
[10]  
DEPENA CA, 1990, RADIOL CLIN N AM, V28, P723